Upper limb deep vein thrombosis
ICD-10 I82.6 · ICD-11 BD71.0

Treatment of Upper Limb Deep Vein Thrombosis with an Indwelling Central Venous Catheter or Port System

This protocol covers catheter-associated upper-extremity deep vein thrombosis (UEDVT) — DVT that develops in the context of an indwelling central venous catheter or port system. The presence of the catheter shapes both the anticoagulation strategy and the question of whether the catheter itself should be removed.

Clinical scenario

Catheter-associated UEDVT represents the predominant secondary form of upper limb DVT. It arises mainly from indwelling central venous lines or port systems, and less frequently from pacemaker or defibrillator leads. Management must account for the ongoing clinical need for the catheter alongside the thrombotic event.

Treatment approach

The approach centers on anticoagulation therapy, with individualized decisions about whether to retain or remove the central venous catheter based on specific clinical circumstances. For cases where catheter patency is compromised, additional targeted interventions may be considered. The structured protocol covers the complete decision framework — including the conditions that guide catheter management and the sequencing of interventions.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1161/circulationaha.111.051276

  1. Catheter-associated UEDVT accounts for the vast majority of secondary forms, resulting mainly from indwelling central venous lines or port systems and less frequently from pacemaker or defibrillator leads.
  2. In patients with catheter-associated UEDVT (with or without cancer), anticoagulation therapy can be discontinued after 3 months if the central venous catheter is removed; if the catheter is not removed, anticoagulation therapy should be continued as long as the catheter remains.
  3. If a catheter is occluded, an attempt to restore patency can be performed by instillation of thrombolytics, with 1 or 2 doses of 2 mg recombinant tissue-type plasminogen activator.
  4. The optimal timing of catheter removal has not been evaluated, but it is usually appropriate to remove the catheter after 3 to 5 days of anticoagulant therapy.
View source ↗